Initial systemic therapy for ovarian cancer
Nicoletta Colombo, MD
University of Milan-Bicocc
European Institute of Oncology
Milan, Italy
Stage IIIB ovarian cancer: Recurrence >12 months following completion of induction chemotherapy
Eric Pujade-Lauraine, MD, PhD
Centre Hospitalier Universitaire
Hotel-Dieu, Paris, France
Support for this activity has been provided by Schering-Plough.
